Rheumatology International

, Volume 39, Issue 1, pp 37–46 | Cite as

Diagnostic/classification criteria in pediatric Behçet’s disease

  • Ezgi Deniz BatuEmail author


Behçet’s disease (BD) is a variable vessel vasculitis characterized by recurrent oral and genital aphthosis accompanied by skin, ocular, gastrointestinal, neurologic, and articular involvement. BD is not common in childhood and the disease characteristics considerably differ between adults and children. 18 diagnostic/classification criteria have been published for BD to date. The pediatric BD (PEDBD) criteria, published in 2015, focused on pediatric BD, while the others mainly based on adult studies and are not validated for children. The aim of this review is to summarize the data about diagnostic/classification criteria for BD and to discuss the use and performance of the current criteria in pediatric BD. The covered topics are the characteristics of the diagnostic/classification criteria sets for BD, the factors restricting the universal use/acceptance of these criteria, and pediatric studies testing the performance of BD criteria sets. Having valid and universally accepted criteria with high performance is very important in pediatric BD as they help us determine patients for our studies and guide us through our clinical practice. There are less than 10 pediatric studies testing the performances of BD diagnostic/classification criteria. Their results suggest that revised ICBD (The International Criteria for BD) has the highest sensitivity, while ISG (The International Study Group) criteria remain as the most specific criteria set. Larger multinational pediatric BD cohorts with adequate control groups are required to compare the performance of the different criteria sets in children and to improve the performance of the existing PEDBD criteria.


Pediatric Behçet’s disease Classification criteria Diagnostic criteria ISG ICBD PEDBD 


Author contributions

BED designed the structure of the article, drafted and critically revised the text, and approved the final version of the manuscript.

Compliance with ethical standards

Conflict of interest

Ezgi Deniz Batu declares that she has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by the author.


  1. 1.
    Batu ED, Ozen S (2012) Pediatric vasculitis. Curr Rheumatol Rep 14(2):121–129. Google Scholar
  2. 2.
    Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11. Google Scholar
  3. 3.
    Kone-Paut I (2016) Behcet’s disease in children, an overview. Pediatr Rheumatol 14(1):10. Google Scholar
  4. 4.
    Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Sadeghi Abdollahi B, Ashofteh F, Mohtasham N, Kavosi H, Masoumi M (2017) Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol 13(1):57–65. Google Scholar
  5. 5.
    Atmaca L, Boyvat A, Yalcindag FN, Atmaca-Sonmez P, Gurler A (2011) Behcet disease in children. Ocul Immunol Inflamm 19(2):103–107. Google Scholar
  6. 6.
    Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Ishigatsubo Y, Takeno M, Kurosawa M, Kaneko T, Mizuki N (2017) Clinical manifestations of Behcet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology 56(11):1918–1927. Google Scholar
  7. 7.
    Shahram F, Nadji A, Akhlaghi M, Faezi ST, Chams-Davatchi C, Shams H, Ghodsi SZ, Davatchi F (2018) Paediatric Behcet’s disease in Iran: report of 204 cases. Clin Exp Rheumatol 36Google Scholar
  8. 8.
    Koné-Paut IBJ (1993) La maladie de Behçet chez l’enfant en France. Arch Fr Pediatr 50:561–563Google Scholar
  9. 9.
    Borlu M, Uksal U, Ferahbas A, Evereklioglu C (2006) Clinical features of Behcet’s disease in children. Int J Dermatol 45(6):713–716. Google Scholar
  10. 10.
    Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA (2016) Paediatric Behcet’s disease: a UK tertiary centre experience. Clin Rheumatol 35(10):2509–2516. Google Scholar
  11. 11.
    Kone-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, Anton J, Hofer M, Chkirate B, Bouayed K, Tugal-Tutkun I, Kuemmerle-Deschner J, Agostini H, Federici S, Arnoux A, Piedvache C, Ozen S, Group P (2015) Consensus classification criteria for paediatric Behcet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 75(6):958–964. Google Scholar
  12. 12.
    Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, Usta A, Kandi B, Durusoy C, Seyhan M, Utas S, Saricaoglu H, Ozden MG, Uzun S, Tursen U, Cicek D, Donmez L, Alpsoy E (2008) Demographic and clinical properties of juvenile-onset Behcet’s disease: a controlled multicenter study. J Am Acad Dermatol 58(4):579–584. Google Scholar
  13. 13.
    Kitaichi N, Ohno S (2008) Behcet disease in children. Int Ophthalmol Clin 48(3):87–91. Google Scholar
  14. 14.
    Davatchi F (2014) Behcet’s disease. Int J Rheum Dis 17(4):355–357. Google Scholar
  15. 15.
    Saadoun D, Wechsler B (2012) Behcet’s disease. Orphanet J Rare Dis 7:20. Google Scholar
  16. 16.
    Chang HK, Kim SY (2003) Survey and validation of the criteria for Behcet’s disease recently used in Korea: a suggestion for modification of the International Study Group criteria. J Korean Med Sci 18(1):88–92. Google Scholar
  17. 17.
    Chang HK, Lee SS, Bai HJ, Lee YW, Yoon BY, Lee CH, Lee YH, Song GG, Chung WT, Lee SW, Choe JY, Kim CG, Chang DK (2004) Validation of the classification criteria commonly used in Korea and a modified set of preliminary criteria for Behcet’s disease: a multi-center study. Clin Exp Rheumatol 22(4 Suppl 34):S21–S26Google Scholar
  18. 18.
    Hewitt J, Escande JP, Lauret P, Perlemuter L (1969) Criteria for diagnosis of Behcet’s syndrome. Bull Soc Fr Dermatol Syphiligr 76(4):565–568Google Scholar
  19. 19.
    Hewitt J, Escande JP, Manesse S (1971) Revision of the diagnostic criteria of Behcet’s syndrome. Presse Med 79(20):901Google Scholar
  20. 20.
    Mason RM, Barnes CG (1969) Behcet’s syndrome with arthritis. Ann Rheum Dis 28(2):95–103Google Scholar
  21. 21.
    Mizushima Y (1988) Recent research into Behcet’s disease in Japan. Int J Tissue React 10(2):59–65Google Scholar
  22. 22.
    International Team for the Revision of the International Criteria for Behcet’s D (2014) The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J EurAcad Dermatol Venereol 28(3):338–347. Google Scholar
  23. 23.
    International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335(8697):1078–1080Google Scholar
  24. 24.
    The International Study Group for Behcet’s disease (1992) Evaluation of diagnostic (‘classification’) criteria in Behcet’s disease–towards internationally agreed criteria. Br J Rheumatol 31(5):299–308Google Scholar
  25. 25.
    Curth HO (1946) Recurrent genito-oral aphthosis with hypopion (Behcet’s syndrome). Arch Dermatol 54:179–196Google Scholar
  26. 26.
    Behcet’s Disease Research Committee of Japan (1974) Behcet’s disease guide to the diagnosis of Behcet’s disease. Japan J Ophthalmol 18:291–294Google Scholar
  27. 27.
    Hubault A, Hamza M (1974) La maladie de Behçet en 1974. In: de Seze S et al (eds) L’actualite rhumatologique, vol 15. Expension Scientifique, Paris, pp 43–55Google Scholar
  28. 28.
    O’Duffy JD (1974) Critères proposés pour le diagnostique de la maladie de Behçet et notes therapeutiques. Rev Med (Paris) 36:2371–2379Google Scholar
  29. 29.
    Cheng SP, Zhang X-Q (1980) Some special clinical manifestations of Behçet’s disease-report of illustrative cases and review of the literature (author’s transl). Chinese J Intern Med 19:15–22Google Scholar
  30. 30.
    Dilsen N, Konice M, Aral O (1986) Our diagnostic criteria of Behcet’s disease-an overview. In: Lehner T, Barnes CG (eds) Recent advances in Behçet’s disease, vol International Congress and Symposium Series 103. London Royal Society of Medicine Services, London, pp 177–180Google Scholar
  31. 31.
    Davatchi F, Shahram F, Akbarian M et al (1993) Accuracy of existing diagnostic criteria for Behçet’s disease. In: Wechsler B, Godeau P (eds) Behcet’s disease. Excerpta Medica International Congress Series 1037, Amsterdam, pp 225–228Google Scholar
  32. 32.
    International Team for the Revision of the International Criteria for Behçet’s disease (2006) Revision of the International Criteria for Behçet’s disease (ICBD). Clin Exp Rheumatol 24(Suppl. 42):S14–S15Google Scholar
  33. 33.
    Dilsen N (2000) About diagnostic criteria for Behcet’s Disease: our new proposal. In: Bang D, Lee ES, Lee S (eds) Behçet’s Disease. Design Mecca Publishing Co., Seoul, pp 101–104Google Scholar
  34. 34.
    Davatchi F, Shahram F, Akbarian M et al (1993) Classification tree for the diagnosis of Behçet’s disease. In: Wechsler B, Godeau P (eds) Behçet’s Disease. Excerpta Medica International Congress Series 1037, Amsterdam, pp 245–248Google Scholar
  35. 35.
    Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, Shahram F, Shams H, Nadji A, Faezi T, Akhlaghi M, Ghodsi Z, Mohtasham N, Ashofteh F (2015) The saga of diagnostic/classification criteria in Behcet’s disease. Int J Rheum Dis 18(6):594–605. Google Scholar
  36. 36.
    Davatchi F, Chams-Davatchi C, Shahram F, Nadji A, Shams H, Ghodsi Z, Akhlaghi M, Naderi N, Sadeghi-Abdolahi B (2007) Pathergy test in Behçet’s disease: change in incidence over the time. APLAR J Rheumatol 10:333–335Google Scholar
  37. 37.
    Batu ED, Ozen S (2015) Vasculitis: do we know more to classify better? Pediatr Nephrol 30(9):1425–1432. Google Scholar
  38. 38.
    Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417. Google Scholar
  39. 39.
    Treudler R, Orfanos CE, Zouboulis CC (1999) Twenty-eight cases of juvenile-onset Adamantiades-Behcet disease in Germany. Dermatology 199(1):15–19. Google Scholar
  40. 40.
    Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N (2004) Behcet’s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31(1):133–139Google Scholar
  41. 41.
    Davatchi F, Chams-Davatchi C, Shams H, Nadji A, Faezi T, Akhlaghi M, Sadeghi Abdollahi B, Ashofteh F, Ghodsi Z, Mohtasham N, Shahram F (2016) Adult Behcet’s disease in Iran: analysis of 6075 patients. Int J Rheum Dis 19(1):95–103. Google Scholar
  42. 42.
    Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R (2017) A national cohort study on pediatric Behcet’s disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J 15(1):84. Google Scholar
  43. 43.
    Kim DY, Choi MJ, Cho S, Kim DW, Bang D (2014) Changing clinical expression of Behcet disease in Korea during three decades (1983–2012): chronological analysis of 3674 hospital-based patients. Br J Dermatol 170(2):458–461. Google Scholar
  44. 44.
    Kone-Paut I, Yurdakul S, Bahabri SA, Shafae N, Ozen S, Ozdogan H, Bernard JL (1998) Clinical features of Behcet’s disease in children: an international collaborative study of 86 cases. J Pediatr 132(4):721–725Google Scholar
  45. 45.
    Aeschlimann FA, Batu ED, Canna SW, Go E, Gul A, Hoffmann P, Leavis HL, Ozen S, Schwartz DM, Stone DL, van Royen-Kerkof A, Kastner DL, Aksentijevich I, Laxer RM (2018) A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis 77(5):728–735. Google Scholar
  46. 46.
    Ozen S, Batu ED (2018) Vasculitis Pathogenesis: can we talk about precision medicine? Front Immunol 9:1892. Google Scholar
  47. 47.
    Alpsoy E, Elpek GO, Yilmaz F, Ciftcioglu MA, Akman A, Uzun S, Karakuzu A (2005) Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behcet’s disease. Dermatology 210(1):31–35. Google Scholar
  48. 48.
    Bonitsis NG, Luong Nguyen LB, LaValley MP, Papoutsis N, Altenburg A, Kotter I, Micheli C, Maldini C, Mahr A, Zouboulis CC (2015) Gender-specific differences in Adamantiades-Behcet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatology 54(1):121–133. Google Scholar
  49. 49.
    Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 82(1):60–76Google Scholar
  50. 50.
    Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, Cacoub P (2010) Mortality in Behcet’s disease. Arthritis Rheum 62(9):2806–2812. Google Scholar
  51. 51.
    Kim DK, Chang SN, Bang D, Lee ES, Lee S (1994) Clinical analysis of 40 cases of childhood-onset Behcet’s disease. Pediatr Dermatol 11(2):95–101Google Scholar
  52. 52.
    Kone-Paut I, Darce-Bello M, Shahram F, Gattorno M, Cimaz R, Ozen S, Cantarini L, Tugal-Tutktun I, Assaad-Khalil S, Hofer M, Kuemmerle-Deschner J, Benamour S, Al Mayouf S, Pajot C, Anton J, Faye A, Bono W, Nielsen S, Letierce A, Tran TA, Committee P-BIE (2011) Registries in rheumatological and musculoskeletal conditions. Paediatric Behcet’s disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology 50(1):184–188. Google Scholar
  53. 53.
    Krause I, Uziel Y, Guedj D, Mukamel M, Harel L, Molad Y, Weinberger A (1999) Childhood Behcet’s disease: clinical features and comparison with adult-onset disease. Rheumatology 38(5):457–462Google Scholar
  54. 54.
    Sibley C, Yazici Y, Tascilar K, Khan N, Bata Y, Yazici H, Goldbach-Mansky R, Hatemi G (2014) Behcet syndrome manifestations and activity in the United States versus Turkey—a cross-sectional cohort comparison. J Rheumatol 41(7):1379–1384. Google Scholar
  55. 55.
    Kobayashi T, Kishimoto M, Swearingen CJ, Filopoulos MT, Ohara Y, Tokuda Y, Oshikawa H, Yoshida K, Utsunomiya M, Kimura M, Okada M, Matsui K, Yazici Y (2013) Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behcet’s syndrome for patients in the US and Japan: data from a large, three-center cohort study. Mod Rheumatol 23(3):547–553. Google Scholar
  56. 56.
    Moosmann T, Veraar C, Brunner J, Fraedrich G, Frech A, Horninger W, Ratzinger G, Streif W, Teuchner B, Willeit J, Zlamy M, De Zordo T, Schirmer M (2018) Differential clinical presentation of Adamantiades-Behcet’s disease in non-endemic and endemic areas: retrospective data from a Middle-European cohort study. Int J Rheum Dis. Google Scholar
  57. 57.
    Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi Abdollahi B (2010) Behcet’s disease: from East to West. Clin Rheumatol 29(8):823–833. Google Scholar
  58. 58.
    Batu ED, Sonmez HE, Sozeri B, Butbul Aviel Y, Bilginer Y, Ozen S (2017) The performance of different classification criteria in paediatric Behcet’s disease. Clin Exp Rheumatol 35(6):119–123Google Scholar
  59. 59.
    Assar S, Sadeghi B, Davatchi F, Ghodsi SZ, Nadji A, Shahram F, Ashofte F, Larimi SR, Sadeghi M (2017) The association of pathergy reaction and active clinical presentations of Behcet’s disease. Reumatologia 55(2):79–83. Google Scholar
  60. 60.
    Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, Shahram F, Ghodsi Z, Nadji A, Akhlaghi M, Faezi T, Shams H, Larimi R, Ashofteh F (2013) Impact of the positive pathergy test on the performance of classification/diagnosis criteria for Behcet’s disease. Mod Rheumatol 23(1):125–132. Google Scholar
  61. 61.
    Faezi ST, Paragomi P, Shahram F, Shams H, Shams-Davatchi C, Ghodsi Z, Nadji A, Akhlaghi M, Davatchi F (2014) Clinical features of Behcet’s disease in patients without oral aphthosis. Mod Rheumatol 24(4):637–639. Google Scholar
  62. 62.
    Mat MC, Goksugur N, Engin B, Yurdakul S, Yazici H (2006) The frequency of scarring after genital ulcers in Behcet’s syndrome: a prospective study. Int J Dermatology 45(5):554–556. Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Rheumatology, Department of Pediatrics, Ankara Training and Research HospitalUniversity of Health SciencesAnkaraTurkey

Personalised recommendations